ArticleAsia Pacific journal of clinical nutrition2026
Burden of cardiovascular disease in China attributable to unbalanced fatty acid intake from 1990 to 2050.
Article in Asia Pacific journal of clinical nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
BACKGROUND AND
objectivesThis study aimed to analyze the trends in death and disability-adjusted life years (DALYs) due to cardiovascular disease (CVD) associated with unbalanced dietary fatty acid intake in China from 1990 to 2021, and to predict the disease burden levels up to 2050. METHODS AND STUDY
designUsing Global Burden of Disease 2021 data, we examined death and DALYs rates by age, sex, and risk fac-tors. Joinpoint regression assessed temporal trends. Decomposition analysis evaluated contributions of population growth, aging, and epidemiological transitions. Age-period-cohort (APC) modeling estimated cohort and period effects. Bayesian Age-Period-Cohort (BAPC) modeling projected future CVD burden.
resultsAge-standardized death and DALYs rates for CVD attributable to low seafood n-3 polyunsaturated fatty acids (PUFAs) and high trans fatty acids declined, while those due to insufficient n-6 PUFAs intake increased. Despite fluctuations, overall CVD burden showed a downward trend. Burden was higher in males and older groups. Population growth drove the absolute increase in burden, while aging and epidemiological shifts had variable effects by risk factor. APC modeling revealed significant age, period, and cohort influences. BAPC projections indicate continued decline in CVD burden from fatty acid imbalances through 2050.
conclusionsThe CVD burden linked to imbalanced fatty acid consumption demonstrated a general decline, with forecasts suggesting a continued decrease by 2050. Older adults and males were highlighted as priority populations for focused interventions. These results can inform the development of targeted prevention and control initiatives.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.